跳至主要内容
临床试验/NL-OMON54174
NL-OMON54174招募中不适用

euroinflammation in frontotemporal lobar degeneration: a multimodal biomarker study - Neuroinflammation in FTLD

eids Universitair Medisch Centrum0 个研究点目标入组 110 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Ability to undergo MRI scanning
  • - For probable FTLD-tau: a clinical diagnosis of PSP, CBS or nfvPPA, or any
  • clinical FTLD spectrum diagnosis with a proven MAPT mutation
  • - For probable FTLD-TDP: a clinical diagnosis of svPPA or any clinical FTLD
  • spectrum diagnosis with a proven GRN mutation or C9orf72 repeat expansion
  • - For presymptomatic mutation carriers: a MAPT mutation, GRN mutation or a
  • C9orf72 mutation withouth clinical sign of a FTLD spectrum phenotype (CDR 0)
  • - For control subjects: no known neurological or psychiatric disorder

排除标准

  • - Other neurological or psychiatric disorder that may affect cognitive
  • functions, such as a brain tumour, multiple sclerosis or drug or alcohol abuse
  • or use of psycho-active medications
  • - CSF profile (β-amyloid, p-tau, t-tau) suggestive of AD pathology
  • - Clinical dementia Rating Scale (CDR) score >1
  • - Contra-indication to undergo MRI
  • - Contra-indication to undergo lumbar puncture

研究者

相似试验